Licensed vaccine
Biothrax
FDA-licensed vaccine · Emergent BioDefense Operations Lansing LLC · STN BL 103821
Key facts
| Trade name | Biothrax |
|---|---|
| Proper name | Anthrax Vaccine Adsorbed |
| Manufacturer | Emergent BioDefense Operations Lansing LLC |
| Submission tracking number (STN) | BL 103821 |
| Recent FDA documents | Package Insert and Information for Patients - Biothrax, Supporting Documents older than three years - Biothrax |
| FDA page updated | Jul 6, 2023 |
| FDA product page | fda.gov |
At a glance
- None FDA approval letters
- 1–9 Supporting documents
- 1–9 Product information documents
- Yes Document full text searchable in Orca1
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-licensed vaccines
The FDA's CBER licenses vaccines for use in the United States. Each product page links the approval letters, package inserts and supporting documents for that vaccine.
Source: U.S. Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Vaccines Licensed for Use in the United States · Source date: